Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by ScienceFirston Apr 28, 2021 8:55am
155 Views
Post# 33081153

Platform for Fund Managers to Profit From Short Sellers

Platform for Fund Managers to Profit From Short SellersAs we thought we could have a break from short-selling ... now this!


Fidelity Launches Platform for Fund Managers to Profit From Short Sellers

Boston firm launched securities-lending business in-house two years ago and is now extending those services to other asset managers



Fidelity Investments Inc. is ramping up a business that helps money managers profit on those eager to bet against stocks.

Fidelity said this week it is launching a platform for fund managers looking to lend out their holdings to other investors, including short sellers. Fidelity’s move is the latest sign that the money-management industry, which once dismissed the business as unnecessary and even a bit unseemly, has come full circle. Lending out securities has emerged as an important source of extra revenue, juicing returns and keeping clients from fleeing to cheaper investments.

The Boston firm launched its securities-lending business in 2019, serving as agent to the company’s own family of funds. The firm is now extending those services to other asset managers. Fidelity Agency Lending is part of the firm’s capital-markets group and employs more than 90 people.

“With pressures on fees and returns, securities lending is a nice way to generate low-risk returns for your shareholders,” said Justin Aldridge, head of the unit.

The revenue on those loans boosts funds’ returns, which helps their managers bring in more client money. As a lending agent, Fidelity in turn keeps a share of that revenue. Lending out a large-cap stock might boost a fund’s return by 0.01% to 0.02%. Loans on less-liquid shares, and in particular those in high demand, might add 0.25% to 0.30%, said Mr. Aldridge.

<< Previous
Bullboard Posts
Next >>